NASDAQ:INMB

INmune Bio, Inc Earning Date

USA |NASDAQ |USD

INMB Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.38 $-0.44 $-0.36
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $970.00K $4.00 $0.00

Inmune Bio, Inc's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

INMB Earnings Date & History Chart

INMB Earnings & Revenue Forecast

INMB Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-0.50 $-0.55 $-0.43
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-1.65 $-1.77 $-1.56
Dec 2022 3 $-2.36 $-2.68 $-2.12

INMB Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.50 $-0.42 $-0.43
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.65 $-1.40 $-1.42
Dec 2022 0 / 0 $-2.36 $-2.04 $-2.09

INMB Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 2 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $970.00K $0.00 $2.90M
Dec 2022 2 $0.00 $0.00 $0.00

INMB Earnings Date & Revenue History

INMB Earnings History

|
Show More
Show More

INMB Revenue History

|
Show More
Show More

Inmune Bio, Inc Next Earnings Date & Report

INMB Next Earnings Date & Report Preview: Sep 2021 (FQ)

INMB's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 3 analysts, the average EPS estimation for Inmune Bio, Inc's next quarterly earnings is $-0.38, with a low EPS estimation of $-0.43, and a high estimation of $-0.28.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.38, the last 2 month trend is $-0.31, and the 3 month trend is $-0.32.

Based on 3 analysts, the average revenue estimation is $970.00K, with a low revenue estimation of $0.00, and a high estimation of $2.90M.

Inmune Bio, Inc Previous Earnings Dates & Reports

INMB Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Inmune Bio, Inc's previous earnings date was Aug 4, 2021 for its fiscal quarter ended Jun 30, 2021.

INMB's earnings per share (EPS) was $-0.44, missing the consensus analysts forecast of $-0.34 by -29.41%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 37.50%, and lower than the same period a year before (Jun 2020) by 120.00%.

Revenues were $4.00.

The company reported a net income of $-6.66M.

Free cash flow for the quarter was $-20.71M , compared to $-5.09M last quarter and $-1.82M a year before.

INMB ended the quarter with $14.49M in total debt, an increase of 10324.46% compared to the previous quarter, and an increase of 9409.12% compared to the same quarter a year before.

INMB Previous Earnings Date & Report Recap: Dec 2020 (FY)

Inmune Bio, Inc's previous annual earnings date was Mar 4, 2021 for its fiscal year ended Dec 31, 2020.

INMB's earnings per share (EPS) was $-1.01, beating the consensus analysts forecast of $-1.09 by -7.34% , and lower than the previous year's EPS (Dec 2019) by 36.49%.

Revenues were $10.92K.

The company reported a net income of $-12.10M.

Inmune Bio, Inc reported a free cash flow of $-8.94M for its fiscal year, compared to $-5.38M a year ago.

The company ended the fiscal year with $160.16K in total debt, a decrease of -4.92% compared to the previous year.